Aug 6, 2026 08:00AM
Jul 13, 2026 04:15PM
Jul 13, 2026 04:15PM
Jun 12, 2026 07:01AM
Jun 12, 2026 07:00AM
May 11, 2026 07:00AM
May 11, 2026 07:00AM MBX Biosciences Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing
May 7, 2026 08:00AM
May 7, 2026 07:01AM
May 7, 2026 07:00AM
Mar 12, 2026 12:50PM
Mar 12, 2026 08:00AM
Mar 9, 2026 10:21AM
Mar 9, 2026 10:21AM CORRECTING & REPLACING -- MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Mar 9, 2026 08:57AM
Mar 9, 2026 08:01AM
Mar 9, 2026 08:00AM
Feb 24, 2026 10:25AM
Jan 22, 2026 08:00AM
Jan 22, 2026 08:00AM
Jan 12, 2026 06:05AM MBX Biosciences to present pipeline updates at JP Morgan conference
Jan 11, 2026 04:00PM
Dec 18, 2025 07:46AM
Dec 11, 2025 05:00PM
Dec 10, 2025 07:00AM
Dec 4, 2025 07:00AM
Dec 3, 2025 07:00AM
Nov 20, 2025 04:01AM Jefferies Reiterates Buy Rating on MBX Biosciences Inc (MBX)
Nov 12, 2025 07:00AM
Nov 6, 2025 08:00AM
Nov 5, 2025 07:00AM
Oct 8, 2025 07:00AM
Sep 25, 2025 07:00AM
Sep 23, 2025 07:00AM
Sep 22, 2025 07:00AM MBX Biosciences reports 63% response rate in hypoparathyroidism trial
Sep 22, 2025 07:00AM
Sep 17, 2025 07:00AM
Sep 4, 2025 08:01AM
Sep 4, 2025 08:00AM
Sep 3, 2025 01:07PM
Aug 14, 2025 07:00AM
Aug 7, 2025 08:00AM MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Aug 7, 2025 07:00AM
Jul 29, 2025 07:00AM
Jul 24, 2025 07:00AM
Jul 8, 2025 07:00AM
Jun 24, 2025 09:17AM
Jun 23, 2025 08:00AM
Jun 17, 2025 07:00AM Microbix Attending & Presenting at Asia Pacific POC 2025
Jun 16, 2025 08:03AM

327,802 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All